UK government-created and EU-backed institutions support Ablatus Therapeutics in its $648,000 round to commercialise a potential treatment for solid cancer tumours.

GE Ventures and Cambia Health Solutions returned to participate in another deal for care coordination platform Caremerge, after backing a $4m round last year.

Tencent-backed healthcare data technology developer iCarbonX has followed a $154m series A round in April with $45m from China Bridge Capital.

OSF Healthcare's investment arm and an unnamed corporate backer both contributed to the heart patient monitor developer's latest round.

As the Indian Institute of Management Ahmedabad's Infuse Ventures fund nears full deployment, the institution prepares to launch the $150m Bharat Innovations Fund.

The oncology radiation gel developer, backed by Varian Medical Systems and Ascension Health in the past, secured the funding from existing investors.

GlaxoSmithKline's corporate venturing unit invested $8.4m to strengthen a series B round already including Pfizer, Roche and Mayo Clinic.

Celgene has backed a funding round for oncology treatment developer Sapience Therapeutics, a spinout of Columbia University.

Celgene has backed a funding round for oncology treatment developer Sapience Therapeutics that also included corporate-backed technology advisory firm TaiAn Technologies.